2-(2-Methyl-1H-indol-3-yl)-1,4-dihydro-2H-benzo[d][1,3]oxazine

ID: ALA5282294

Max Phase: Preclinical

Molecular Formula: C17H16N2O

Molecular Weight: 264.33

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1[nH]c2ccccc2c1C1Nc2ccccc2CO1

Standard InChI:  InChI=1S/C17H16N2O/c1-11-16(13-7-3-5-9-15(13)18-11)17-19-14-8-4-2-6-12(14)10-20-17/h2-9,17-19H,10H2,1H3

Standard InChI Key:  YOUQDMMVNFUQNX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
   -2.9677   -0.2896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2530    0.1226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5411   -0.2892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5411   -1.1144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2512   -1.5262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9677   -1.1181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8265    0.1233    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1118   -0.2892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1118   -1.1145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8265   -1.5271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6028    0.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6890    0.9436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4958    1.1150    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9083    0.4008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3563   -0.2121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7125    0.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9677   -0.5553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4198   -1.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6125   -0.9999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1055    1.5271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
  4 10  1  0
 11  8  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 14 16  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 15 19  1  0
 12 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5282294

    ---

Associated Targets(Human)

MGAM Tclin Alpha glucosidase (860 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 264.33Molecular Weight (Monoisotopic): 264.1263AlogP: 4.12#Rotatable Bonds: 1
Polar Surface Area: 37.05Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.88CX Basic pKa: CX LogP: 3.50CX LogD: 3.50
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.69Np Likeness Score: -0.20

References

1. Zhu Y, Zhao J, Luo L, Gao Y, Bao H, Li P, Zhang H..  (2021)  Research progress of indole compounds with potential antidiabetic activity.,  223  [PMID:34192642] [10.1016/j.ejmech.2021.113665]

Source